CAS 1093070-16-6

GRL0617

CAS: 1093070-16-6

GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).

Formel: C₂₀H₂₀N₂O

Reinheit: 99.31%

Farbe und Form: Solid

Molekulargewicht: 304.39

Ref: TM-T11464

GRL0617

CAS: 1093070-16-6

Formel: C₂₀H₂₀N₂O

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 304.3856

Ref: IN-DA01KKBV

GRL0617

CAS: 1093070-16-6

GRL0617

Formel: C₂₀H₂₀N₂O

Reinheit: ≥98%

Molekulargewicht: 304.39

Ref: 54-BUP12825

GRL 0617

CAS: 1093070-16-6

A novel non-covalent inhibitor of the PLpro protease from SARS-CoV-2 and SARS-CoV viruses. GRL 0617 inhibits the proteolytic processing of the viral polypeptide. As PLpro also acts as a protease in pathways involved in innate immunity, there are indications that it can promote immunity against the virus.

Formel: C₂₀H₂₀N₂O

Reinheit: Min. 98 Area-%

Farbe und Form: Powder

Molekulargewicht: 304.39 g/mol

Ref: 3D-BG178727

GRL0617

CAS: 1093070-16-6

(R)-5-amino-2-methyl-N-(1-(naphthalen-1-yl)ethyl)benzamide

Formel: C₂₀H₂₀N₂O

Reinheit: 99%

Molekulargewicht: 304.39

Ref: IN-DG01200315